Business Standard

Viable road to affordable health care

This focus on a key social sector is to be appreciated

Image
Premium

Subir Roy
After subjecting a large number of drug formulations, which come under the national list of essential medicines and coronary stents to price control, the government has now indicated that it plans to make it obligatory for doctors to prescribe medicines only by their generic or molecular names and not brand names (e.g., ciprofloxacin and not Cifran). An indication of which way the government’s thinking is going was already available in the Union Budget.
 
While dwelling on the need to use generic names in prescriptions so as not to promote costlier branded products, the prime minister referred to the exorbitant
Disclaimer: These are personal views of the writer. They do not necessarily reflect the opinion of www.business-standard.com or the Business Standard newspaper

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in